Canada negotiates accelerated delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine

The Government of Canada continues to work to ensure that Canadians have access to safe, effective COVID-19 vaccines as soon as possible. Successful efforts to expedite this access demonstrate Canada’s commitment to ensure more people in Canada have access to vaccines even sooner.

Today, the Honourable Anita Anand, Minister of Public Services and Procurement, announced that Canada has negotiated an accelerated delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine, and will receive all 40 million of its secured doses from Pfizer-BioNTech by the end of September.

This means that Canada will receive 2.8 million additional doses of Pfizer between April and June and an additional 6.2 million doses between July and September than was originally scheduled.

The Government of Canada has also purchased an additional 4 million doses of the Moderna vaccine, bringing the total number of secured doses to 44 million. The additional 4 million doses are expected to arrive by the end of September.

Canada is now expected to receive 84-million doses of Pfizer-BioNTech and Moderna vaccines by the end of September 2021.

This means more people in Canada will be vaccinated sooner and also further protects Canada’s against supply chain disruptions so that we can provide a vaccine to everyone in Canada for whom these authorized COVID-19 vaccines are recommended by the end of September 2021.

 

Comments are closed.